NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,022 Cr | ₹973 Cr | ₹891 Cr | ₹1,004 Cr | ₹1,187 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹973 Cr |
| Mar2023 | ₹891 Cr |
| Mar2022 | ₹1,004 Cr |
| Mar2021 | ₹1,187 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 5.01 | |
| Mar2024 | ₹973 Cr | 9.19 | |
| Mar2023 | ₹891 Cr | -11.25 | |
| Mar2022 | ₹1,004 Cr | -15.46 | |
| Mar2021 | ₹1,187 Cr | - | |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹317.8 Cr | 2.7% | 3.6% | -61.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,529.0 Cr | 1.4% | 3.5% | -5.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,067.0 Cr | -3.9% | 6.6% | 15.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,376.0 Cr | 7% | 7.8% | 19.8% | Stock Analytics | |
| CIPLA | ₹122,773.0 Cr | 0.8% | 0.2% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,595.0 Cr | 0.9% | -2.8% | -5.8% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 2.7% |
3.6% |
-61.7% |
| SENSEX | 1.2% |
2.8% |
6.3% |
You may also like the below Video Courses